Press Release Jan 06 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing the launch of Topiramate Extended-Release Capsules. The product has received final approval from the United States Food and Drug Administration for marketing in various dosages. Zydus is the first company to launch this medication in the United States, which is indicated for epilepsy and migraine prophylaxis.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Dec 30 2022
- Loss of Share Certificates
- Press Release Dec 22 2022
- Press Release Dec 10 2022
- Press Release Dec 02 2022
Later from Zydus Lifesciences
- Press Release Jan 10 2023
- Zydus Lifesciences Limited Press Release Jan 12 2023
- Zydus Lifesciences Limited Press Release Jan 16 2023
- Press Release Jan 27 2023
- Press Release Feb 15 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences